One of Eli Lilly & Co.’s most highly anticipated experimental medicines helped diabetic patients lose more weight than any ...

Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.

WASHINGTON, March 12 (Reuters) - Compounded weight-loss drugs that contain vitamin B12 and the main ingredient in Eli Lilly's ...

Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral ...

Weight-loss with Lilly's GLP-1 pill plateaus for most patients Orforglipron improves cardiovascular risk factors, reduces inflammation marker by 47.7% High-dose orforglipron group sees 10.3% dropout ...

Last week, during the annual J.P. Morgan Healthcare Conference, also known as JPM Week, Nvidia announced a slew of healthcare-related partnerships. Perhaps the most notable was the joint, co-located ...

Sept. 16 (UPI) --Medical company Eli Lilly said Tuesday around $5 billon will be go toward construction of its new facility in Virginia just west of Richmond. The Indiana-based Eli Lilly said its new ...

Eli Lilly and Co. and Indiana University announced a new agreement that would see the drugmaker provide up to $40 million over five years to the university to bolster clinical trials and enhance care ...

Form Health , the national leader in science-based obesity and cardiometabolic care, today announced it has joined Eli Lilly and Company's new Lilly Employer Connect platform, helping employers expand ...